| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (ACH-0204) |
- |
- |
4 － ? |
Ethidium bromide (EtBr)  |
1279 |
| Staphylococcus aureus (ACH-0216) |
- |
- |
0.008 － ? |
ACH-702 |
1279 |
| Staphylococcus aureus (ACH-0216) |
- |
- |
0.125 － ? |
Gemifloxacin |
1279 |
| Staphylococcus aureus (ACH-0216) |
- |
- |
0.25 － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
1279 |
| Staphylococcus aureus (ACH-0216) |
- |
- |
2 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1279 |
| Staphylococcus aureus (ACH-0216) |
- |
- |
4 － ? |
Ethidium bromide (EtBr) |
1279 |
| Staphylococcus aureus (ACH-0231) |
- |
- |
0.5 － ? |
ACH-702 |
1279 |
| Staphylococcus aureus (ACH-0231) |
- |
- |
16 － ? |
Ethidium bromide (EtBr) |
1279 |
| Staphylococcus aureus (ACH-0231) |
- |
- |
>64 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1279 |
| Staphylococcus aureus (ACH-0231) |
- |
- |
>64 － ? |
Gemifloxacin |
1279 |
| Staphylococcus aureus (ACH-0231) |
- |
- |
64 － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
1279 |
| Staphylococcus aureus (Ap01) |
- |
- |
0.78 － ? |
Arbekacin |
730 |
| Staphylococcus aureus (Ap01) |
- |
- |
1.56 － ? |
2"-amino-2"-deoxyarbekacin |
730 |
| Staphylococcus aureus (AS31593) |
- |
- |
32 － ? |
Eperezolid (PNU-100592) |
215 |
| Staphylococcus aureus (AT 3 + erythromycin-susceptible + methicillin-resistant) |
- |
- |
1 － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
289 |
| Staphylococcus aureus (AT 3 + erythromycin-susceptible + methicillin-resistant) |
- |
- |
1 － ? |
Roxithromycin |
289 |
| Staphylococcus aureus (AT 3 + erythromycin-susceptible + methicillin-resistant) |
- |
- |
2 － ? |
Miocamycin (Miokamycin) |
289 |
| Staphylococcus aureus (ATCC 06538) |
- |
- |
1 － ? |
Ampicillin (Omnipen) |
1047 |
| Staphylococcus aureus (ATCC 06538) |
- |
- |
4 － ? |
Streptomycin |
1047 |
| Staphylococcus aureus (ATCC 10231) |
- |
- |
125 － ? |
Kuwanon G |
281 |
| Staphylococcus aureus (ATCC 10832) |
- |
- |
2 － ? |
Cefaclor (Ceclor, Ceclor CD) |
857 |
| Staphylococcus aureus (ATCC 10832) |
- |
- |
4 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
857 |
| Staphylococcus aureus (ATCC 10832) |
- |
- |
64 － ? |
Poly(γ -glutamic acid) sodium salt |
857 |
| Staphylococcus aureus (ATCC 10832) |
- |
- |
>256 － ? |
Poly(γ -glutamic acid) calcium salt |
857 |
| Staphylococcus aureus (ATCC 11632 + methicillin-susceptible) |
- |
- |
<0.016 － ? |
NB2001 |
186 |
| Staphylococcus aureus (ATCC 11632 + methicillin-susceptible) |
- |
- |
≤0.016 － ? |
Triclosan |
186 |
| Staphylococcus aureus (ATCC 11632 + methicillin-susceptible) |
- |
- |
0.25 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
186 |
| Staphylococcus aureus (ATCC 11632 + methicillin-susceptible) |
- |
- |
0.25 － ? |
Vancomycin (Vancocyn, Lyphocin) |
186 |